No Data
No Data
Dizhe Pharmaceutical (688192.SH): Zhang Xiaolin has cumulatively reduced his shareholding by 0.3977%.
On May 8, Gelonghui announced that Dize Pharmaceutical (688192.SH) recently received a notice of the shareholding reduction results issued by Dr. Zhang Xiaolin. As of the close on May 7, 2025, Dr. Zhang Xiaolin has cumulatively reduced his holdings in the company by 1,827,000 shares through centralized bidding, accounting for 0.3977% of the company's current total share capital. This shareholding reduction plan has been completed.
Dizal (Jiangsu) Pharmaceutical Co., Ltd.'s (SHSE:688192) Path To Profitability
Digel Pharmaceuticals: Digel Pharmaceuticals: 2024 Annual Report Summary
Digel Pharmaceuticals: Digel Pharmaceuticals: Report for the First Quarter of 2025
Digel Pharmaceuticals: Digel Pharmaceuticals: 2024 Annual Report
Digel Pharmaceuticals: 2024 Annual Report